Spencer Roach

Director, CMC Analytical Development and Quality Control at Constellation Pharmaceuticals, A MorphoSys Company
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Boston, Massachusetts, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Director, CMC Analytical Development and Quality Control
      • Feb 2021 - Present

      Responsible for all CMC analytical development and quality control activities for Constellation’s clinical programs, covering pre-clinical to Phase IIIDirects a global network of CDMO analytical laboratories, covering all steps from starting materials to packaged drug productsBuilt from scratch a high-performing team of analytical scientists

    • Associate Director, CMC Analytical Development
      • Feb 2020 - Feb 2021

    • Senior Manager, CMC Analytical Development
      • Oct 2018 - Feb 2020

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Manager, Quality Control Methods
      • 2015 - 2018

      Managed quality control and analytical development activities for commercial-stage small molecule drug substances and drug products in a virtual environment. Responsible for life-cycle management and troubleshooting of post-approval test methods for oral solid dosage products. Managed quality control and analytical development activities for commercial-stage small molecule drug substances and drug products in a virtual environment. Responsible for life-cycle management and troubleshooting of post-approval test methods for oral solid dosage products.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Associate Scientist
      • 2011 - 2015

      Developed, validated, and transferred analytical methods for parenteral small molecule formulations. Developed, validated, and transferred analytical methods for parenteral small molecule formulations.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Chemist III
      • 2006 - 2011

      Developed and validated analytical methods for fermentation-derived small molecule drug substances and solid dosage drug products. Developed and validated analytical methods for fermentation-derived small molecule drug substances and solid dosage drug products.

Education

  • University of Chicago

Community

You need to have a working account to view this content. Click here to join now